Your institution may have access to this item. Find your institution then sign in to continue.
Title
Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial.
Authors
Brown, Simon G A; Wiese, Michael D; Blackman, Konrad E; Heddle, Robert J
Abstract
The jack jumper ant Myrmecia pilosula is responsible for about 90% of ant venom anaphylaxis in southeastern Australia. We aimed to establish whether M pilosula venom immunotherapy (VIT) prevents lifethreatening sting anaphylaxis in otherwise healthy adults.